Variant report

Variant	rs16843503
Chromosome Location	chr4:2868935-2868936
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:2868793-2868971	H1-hESC	embryonic stem cell:	n/a	n/a
2	POLR2A	chr4:2868831-2869878	HepG2	liver:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:2868702..2870783-chr4:2881589..2883580,3	K562	blood:
2	chr4:2867681..2870567-chr4:2936383..2939288,2	MCF-7	breast:
3	chr4:2866956..2870306-chr4:2932983..2937533,4	K562	blood:

Variant related genes	Relation type
ADD1	TF binding region
ENSG00000087274	Chromatin interaction
ENSG00000249673	Chromatin interaction
ENSG00000109736	Chromatin interaction

Extended variants
information (count: 8 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs10010375	1.00[JPT][hapmap]
rs13106867	1.00[MKK][hapmap]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv3418626	chr4:2741174-3461492	Genic enhancers Weak transcription Active TSS Strong transcription Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	63 gene(s)	inside rSNPs	diseases
2	esv3397632	chr4:2741239-3460583	Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS Strong transcription Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	63 gene(s)	inside rSNPs	diseases
3	nsv593435	chr4:2770772-2881256	Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases
4	nsv1010533	chr4:2792848-2873441	Enhancers Bivalent/Poised TSS Genic enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	14 gene(s)	inside rSNPs	diseases
5	nsv521858	chr4:2846799-2881256	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
6	nsv524060	chr4:2850142-2881256	Weak transcription Flanking Active TSS Enhancers Strong transcription Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:123 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:2857000-2877000	Weak transcription	Dnd41	blood
2	chr4:2857400-2870000	Enhancers	Primary T helper cells PMA-I stimulated	--
3	chr4:2857400-2877600	Weak transcription	HMEC	breast
4	chr4:2859200-2869400	Enhancers	Skeletal Muscle Female	skeletal muscle
5	chr4:2860600-2869200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
6	chr4:2860800-2869400	Enhancers	Duodenum Smooth Muscle	Duodenum
7	chr4:2860800-2871000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr4:2861400-2872600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr4:2862000-2869800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr4:2862000-2869800	Enhancers	Fetal Intestine Small	intestine
11	chr4:2862600-2869800	Enhancers	HepG2	liver
12	chr4:2863000-2869000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr4:2863000-2869000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr4:2864000-2869400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
15	chr4:2864200-2869000	Weak transcription	Placenta Amnion	Placenta Amnion
16	chr4:2864600-2869000	Weak transcription	H1 Cell Line	embryonic stem cell
17	chr4:2864600-2869200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
18	chr4:2864600-2869200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
19	chr4:2864600-2869200	Enhancers	Brain Hippocampus Middle	brain
20	chr4:2864600-2869400	Enhancers	Skeletal Muscle Male	skeletal muscle
21	chr4:2864600-2869800	Weak transcription	Thymus	Thymus
22	chr4:2864600-2877400	Weak transcription	NHEK	skin
23	chr4:2864800-2869000	Weak transcription	H9 Cell Line	embryonic stem cell
24	chr4:2864800-2869400	Weak transcription	Pancreatic Islets	Pancreatic Islet
25	chr4:2864800-2869600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr4:2864800-2869600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr4:2864800-2869600	Weak transcription	Brain Inferior Temporal Lobe	brain
28	chr4:2864800-2869600	Weak transcription	Monocytes-CD14+_RO01746	blood
29	chr4:2864800-2869800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
30	chr4:2864800-2869800	Weak transcription	Gastric	stomach
31	chr4:2864800-2873200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr4:2865000-2869600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr4:2865400-2869000	Weak transcription	HSMMtube	muscle
34	chr4:2865400-2869600	Enhancers	Fetal Lung	lung
35	chr4:2865600-2869200	Enhancers	Colon Smooth Muscle	Colon
36	chr4:2865600-2870200	Weak transcription	Placenta	Placenta
37	chr4:2865600-2871200	Enhancers	Primary hematopoietic stem cells	blood
38	chr4:2865600-2871400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
39	chr4:2865800-2869000	Enhancers	Primary B cells from peripheral blood	blood
40	chr4:2866000-2869800	Enhancers	Adipose Nuclei	Adipose
41	chr4:2866200-2869200	Enhancers	HUES64 Cell Line	embryonic stem cell
42	chr4:2866200-2869200	Enhancers	Cortex derived primary cultured neurospheres	brain
43	chr4:2866200-2869400	Enhancers	HUES6 Cell Line	embryonic stem cell
44	chr4:2866200-2869600	Enhancers	HUES48 Cell Line	embryonic stem cell
45	chr4:2866200-2869600	Enhancers	Brain Substantia Nigra	brain
46	chr4:2866200-2869800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr4:2866200-2869800	Enhancers	Liver	Liver
48	chr4:2866200-2869800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr4:2866200-2872400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr4:2866400-2869400	Enhancers	Stomach Smooth Muscle	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links